Antonio Alcala Malave
Antonio Alcalá Malavé (Malaga, Spain, 1964) is a neuroscientist, specializing in ophthalmology and neurology of vision. He has been awarded 4 national prizes in medicine by the Institute of Spain through the Royal Academy of Medicine (Best Cardiology Research Award in 2000 and Best Chronopathology Research Award in 2008) and through The Royal Academy of Medicine and Surgery of Cadiz (Best Ophthalmology Research Award in 2002 and Best Alzheimer's disease Rearch Work Award in 2005)..[1]
He is a specialist on the application of neuroscience to vision and emotions. He is a former professor of advanced studies in clinical chemistry and molecular pathology at the University of Málaga. He is professor of Regressive Therapy and Clinical Hypnosis and Neuroscience at the International Association of Clinical and Experimental Hypnosis.
His main line of research is based on the connection between cardiovascular diseases and dementias with vision. In 2001 and 2002 he published two works in which he shows that the Brodman areas 17, 18 and 19 do not produce the physical-chemical phenomenon of vision, but can inform about the cardiovascular risk. Specifically, the papers reported that patients with high levels of cholesterol lose color vision and that a drug used for treating myocardial infarction (pravastatin) made vary from black to white to the full color spectrum. Between 2007 and 2010 he reports that the cardiovascular risk from hypercholesterolemia produces a visual failure when capturing the light which is measurable using computerized perimetry, a test tha, so far that used for glaucoma diagnosis. He also reports connections between dementias and brain areas for vision.
Biography[edit]
He graduated in Medicine and Surgery 1989 at the University of Malaga. He studied his doctorate in Ophthalmology at the Instituto Castroviejo in the Complutense University of Madrid and at the Instituto de Oftalmobiologia Aplicada at the University of Valladolid between 1993 and 1995. Additionally, in 2010 he received a PhD in Clinical Chemistry and Molecular Pathology at the University of Malaga.
Works[edit]
Some of his main publications:
- Comparative study of the impact of diet versus pravastatin on color vision in Brodmann area 19 detected by computerized chromatic analysis (The CARDIOCOLOUR Study)[2] is ranked 47th in the Top 100 Best Articles in Neuroscience.[3]
- Statins improve visual field alterations related to hypercholesterolemia[4] is ranked 4th as scientific discovery about statins[5] and 13th in the World's Top 100 Best Articles in Ophthalmology associated with cardiology. [6]. It is also ranked 44th in the world by relevance of the biomedical discovery on cholesterol and other lipids in blood [7]
- Hypercholesterolemia produces visual field alterations detectable with computerized perimetry[8] is ranked 9th as scientific discovery about statins [9] [10] It is also ranked 20th in the World's Top 100 Best Articles in Cardiovascular Medicine [11]).
These last two, are ranked 8th and 9th in the top best articles about retina and microcirculation published in the journal Atherosclerosis[12]
Honors[edit]
- 2000 Royal Academy of Medicine Award for the Best Cardiology Research
- 2002 Royal Academy of Medicine and Surgery of Cadiz Award (Western Andalusia area) for the Best Ophthalmology Research
- 2002 Corresponding Member at The Royal Academy of Medicine and Surgery of Cadiz (Western Andalusia area). Qv Reales Academias
- 2005 Royal Academy of Medicine and Surgery of Cadiz Award for the Best Alzheimer's Disease Research Work
- 2007 Knight Commander of Justice at the Order of Saint Lazarus of Jerusalem
- 2008 Royal Academy of Medicine Award for the Best Chronopathology Research
- 2009 Medal of Honor of the Grand Priory in Spain of the Order of Saint Lazarus
- 2009 Scientific Committee Member of the College of Physicians[13]
- 2010 Knight at the Order of Saint Michael of the Wing (Portugal)
- 2010 Merit Academician of the Malaga Academy of Sciences. Qv Reales Academias
- 2011 Medal of Honor of the Grand Priory in Spain of the Order of Saint Lazarus of Jerusalem, Malta, Bethlehem and Nazareth
- 2015 Professor of Hypnosis and Neuroscience at the International Association of Clinical and Experimental Hypnosis
- 2015 Professor of Hypnosis and Neuroscience at the Universitas Privada Hipnosis Clínica ( U.P.H.C)
Books[edit]
- 2015 "Genética de la emoción: el origen de la enfermedad" (Genetics of the emotion: the origin of the disease) Ediciones B[14]
- 2016 " Hipnosis clínica y psicologia" (Clinical hypnosis and psychology) AIHCE
[6]as coauthor
References[edit]
- ↑ [1]
- ↑ Alcalá, Antonio; Morell, Miguel; Rius, Francisca (1 December 2002). "Comparative Study of the Impact of Diet Versus Pravastatin on Color Vision in Brodman Area 19 Detected by Computerized Chromatic Analysis (CARDIOCOLOUR Study)". Revista Española de Cardiología (English Edition). 55 (12): 1243–1250. ISSN 1885-5857.
- ↑ "Pre study sensation disorders disease finding *count=100 - BioMedLib™ search engine".
- ↑ Alcalá, Antonio; Jansen, Sergio; Téllez, Teresa; Gómez-Huelgas, Ricardo; Pérez, Olga; Egido, Jesús; Farkouh, Michael E. (April 2010). "Statins improve visual field alterations related to hypercholesterolemia". Atherosclerosis. 209 (2): 510–514. doi:10.1016/j.atherosclerosis.2009.10.001. PMID 19892351.
- ↑ [2]
- ↑ Current Problems in Cardiology
- ↑ "Cholesterol LDL - RecentMedicalFindings™".
- ↑ Alcalá, Antonio; Jansen, Sergio; Farkouh, Michael E.; Morell, Miguel (November 2007). "Hypercholesterolemia is associated with visual field alterations detectable with computerized perimetry". Atherosclerosis. 195 (1): e167–e171. doi:10.1016/j.atherosclerosis.2007.01.013. PMID 17350633.
- ↑ [3]
- ↑ [4].
- ↑ [5]
- ↑ "Atherosclerosis - Advanced Search".
- ↑ "Home | commalaga".
- ↑ "Megustaleer".
This article "Antonio Alcala Malave" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Antonio Alcala Malave. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
